Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects

Despite advances, patients with metastatic colorectal cancer (mCRC) still have poor long-term survival. Identification of molecular subtypes is important to guide therapy through standard treatment pathways and holds promise for the development of new treatments. Following standard first- and second...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Marissa, Lum, Caroline, Latham, Sarah, Tipping Smith, Sam, Prenen, Hans, Segelov, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369412/
https://www.ncbi.nlm.nih.gov/pubmed/32765085
http://dx.doi.org/10.2147/CMAR.S213236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369412/
https://www.ncbi.nlm.nih.gov/pubmed/32765085
http://dx.doi.org/10.2147/CMAR.S213236

Ejemplares similares